Indefinite Delivery Contract 36C24426D0074
Award Date 6/1/26
Last Date to Order 5/31/31
Federal Agency
Awardee
Ultimate Awardee
Not listed NAICS Category
PSC Category
Federal Contract Vehicle
- Not listed
Pricing Type
Firm Fixed Price
Legislative Mandate
Not listed National Interest Action
None
Award Type
Single
Primary Consortia Member
Not listed Similar IDVs
- The Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 4 awarded a single award indefinite delivery contract to Cytopath Biology Lab Inc. to provide cytopathology and ThyroSeq testing services. Under the contract, Cytopath Biology Lab Inc. leverages its Cblpath division to conduct diagnostic pathology testing at its laboratory in Lebanon, Pennsylvania. Three firm fixed price delivery orders have been issued against the contract to date, valued at...
- The Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 19 awarded a blanket purchase agreement to Cytopath Biopsy Lab Inc., doing business as Cblpath, to provide molecular thyroid mutation reference testing services. The solicitation aimed to procure specialized diagnostic testing to help determine if thyroid nodules detected in veterans were benign or malignant. Under the IDV, Cblpath has received four firm fixed price call orders totaling $372,000...
- Veterans Integrated Service Network 1 (VISN 1), a civilian component of the Department of Veterans Affairs, awarded a single-award Blanket Purchase Agreement valued at $2.88 million to Cytopath Biopsy Lab Inc. (operating as Cblpath) on September 30, 2021, with a performance period extending through September 29, 2026. The BPA establishes an indefinite delivery vehicle through which VISN 1 procures thyroid testing laboratory services to support cancer screening and diagnostic capabilities...
- This Indefinite Delivery Contract (IDC) was awarded by the U.S. Department of Veterans Affairs (VA) Veterans Integrated Service Network 2 to Cytopath Biopsy Lab Inc., a for-profit medical laboratory specializing in cancer screening and diagnosis using next-generation genomic sequencing. The contract, valued at $322,400, is for the provision of cytopathology and ThyroSequence genetic testing services to support the VA's cancer screening and diagnosis programs for veterans. Under this IDC, the...
- The Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 19 (VA-VHA) awarded a single-award Blanket Purchase Agreement (BPA) Call contract to Cytopath Biopsy Lab Inc., doing business as Cblpath, for ThyroSeq testing services. With a period of performance from September 1, 2023 through August 31, 2024 and potential value of $360,000, the firm fixed price BPA Call aims to procure molecular diagnostic testing of thyroid nodules utilizing Cblpath's...
- The Department of Veterans Affairs (VA) Veterans Health Administration (VHA) has awarded a Blanket Purchase Agreement (BPA) to Cytopath Biopsy Lab Inc., doing business as Cblpath, for the provision of ThyroSeq genomic classifier tests. Cblpath is a provider of specialized anatomic pathology and molecular diagnostic laboratory services, and has held multiple federal contracts with the VA and Defense Health Agency to deliver ThyroSeq testing to support cancer screening and diagnosis programs for...
- Cytopath Biopsy Lab Inc. (operating as Cblpath) was awarded a single-award Indefinite Delivery Contract (IDC) valued at $1.8 million by the Department of Veterans Affairs' Veterans Integrated Service Network 2 (VISN 2) on February 13, 2023, with an ultimate completion date of February 12, 2027. The contract procures ThyroSequence testing services, a proprietary molecular diagnostic technology that performs genomic sequencing analysis of thyroid nodules to assess cancer risk and support...
- This Indefinite Delivery Contract (IDC) was awarded by the U.S. Department of Veterans Affairs (VA) to Cytopath Biopsy Lab Inc., operating as Cblpath, to provide ThyroSeq laboratory tests to determine the malignancy of thyroid nodules in order to support surgical decisions for veterans. The single-award IDC has a ceiling value of $500,000 and a period of performance through August 6, 2026. Under this IDC, the VA has issued multiple firm-fixed-price delivery orders ranging from $22,000 to $72,000...
- This Indefinite Delivery Contract (IDC) was awarded by the Department of Veterans Affairs (VA) Veterans Health Administration to Cytopath Biopsy Lab Inc., doing business as Cblpath, to provide ThyroSeq molecular diagnostic testing services to support cancer screening and diagnosis programs for veterans. Under this $838,000 single-award IDC, Cblpath will deliver firm fixed price task orders to perform ThyroSeq genetic testing at their facilities in Port Chester, New York and Gobernador Piñero,...
- This Blanket Purchase Agreement (BPA) was awarded by the U.S. Department of Veterans Affairs (VA), specifically the Veterans Integrated Service Network 6, to Cytopath Biopsy Lab Inc., operating under the trade name Cblpath. The contract, with a total ceiling value of $2,250,313.00, is for the provision of Cytopath's proprietary ThyroSeq genomic testing services to support cancer screening and diagnosis programs for veterans and active military personnel. The BPA includes multiple task orders...